Literature DB >> 16426832

Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin.

Shuihua Zhang1, Guang Ji, Jianwen Liu.   

Abstract

Puerarin is a major isoflavonoid compound isolated from Pueraria lobata, an edible vine used widely for various medicinal purposes. It has been used for centuries in China to counteract alcohol intoxication. However, the effects of puerarin on chemical-induced liver fibrosis have not been reported. In the present study, we investigated the effects of puerarin on liver fibrosis in Wistar rats induced by alcohol plus carbon tetrachloride administration. Liver fibrosis was produced in rats by treatment with a mixture (50% alcohol, 8 g/kg per day; corn oil, 2 g/kg per day; pyrazole, 24 mg/kg per day; ig) once a day and by intraperitoneal injection of 0.25 ml/kg of a 25% solution of carbon tetrachloride in olive oil twice a week for 8 weeks. After 8 weeks, treatment with puerarin (0.4 and 0.8 g/kg ig, daily for 4 weeks) was conducted to examine its therapeutic effects. At the same time, the model group and treatment group continued to receive the chemical mixture, while the control group received saline instead of the chemical mixture. Upon pathological examination, the puerarin-treated rats significantly reversed the symptoms of liver fibrosis and other hepatic lesions. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), as indexes of hepatic cell disruption, were reduced with puerarin treatment, whereas no significant effect was discovered in the levels of alkaline phosphatase (ALP) and gamma-glutamyltransferase (GGT) activities. A significant increase in apoptosis of activated hepatic stellate cell (HSC) was found by flow cytometric analysis of the hepatic tissues. And the expression of bcl-2 mRNA was down-regulated after puerarin administration. Consequently, all these results showed that puerarin could effectively reverse chemical-induced liver fibrosis in experimental rats, via the recovery of hepatic injury as well as the induction of apoptosis in activated HSC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16426832     DOI: 10.1016/j.jnutbio.2005.09.002

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  15 in total

Review 1.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

2.  Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model.

Authors:  Huan Xu; Mengying Hu; Mengrui Liu; Sai An; Kaiyun Guan; Menglin Wang; Lei Li; Jing Zhang; Jun Li; Leaf Huang
Journal:  Biomaterials       Date:  2020-01-17       Impact factor: 12.479

3.  Development of an enzyme-linked immunosorbent assay to determine puerarin and its aglycone daidzein.

Authors:  Benyakarn Pongkitwitoon; Seiichi Sakamoto; Hiroyuki Tanaka; Ryota Tsuchihashi; Junei Kinjo; Satoshi Morimoto; Waraporn Putalun
Journal:  J Nat Med       Date:  2010-07-24       Impact factor: 2.343

4.  The preventive effects of heparin-superoxide dismutase on carbon tetrachloride-induced acute liver failure and hepatic fibrosis in mice.

Authors:  Jinfeng Liu; Haining Tan; Yongfu Sun; Shuai Zhou; Jichao Cao; Fengshan Wang
Journal:  Mol Cell Biochem       Date:  2009-02-26       Impact factor: 3.396

5.  Puerarin suppresses proliferation of endometriotic stromal cells partly via the MAPK signaling pathway induced by 17ß-estradiol-BSA.

Authors:  Wen Cheng; Lizao Chen; Shengsheng Yang; Jie Han; Dongxia Zhai; Jian Ni; Chaoqin Yu; Zailong Cai
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

6.  Mucoadhesive microparticles for gastroretentive delivery: preparation, biodistribution and targeting evaluation.

Authors:  Jing-Yi Hou; Li-Na Gao; Fan-Yun Meng; Yuan-Lu Cui
Journal:  Mar Drugs       Date:  2014-12-01       Impact factor: 5.118

7.  Urine metabolic profile changes of CCl4-liver fibrosis in rats and intervention effects of Yi Guan Jian Decoction using metabonomic approach.

Authors:  Xiaojun Gou; Qing Tao; Qin Feng; Jinghua Peng; Yu Zhao; Jianye Dai; Wenyu Wang; Yongyu Zhang; Yiyang Hu; Ping Liu
Journal:  BMC Complement Altern Med       Date:  2013-06-03       Impact factor: 3.659

8.  Effects of Puerariae Radix Extract on Endotoxin Receptors and TNF-α Expression Induced by Gut-Derived Endotoxin in Chronic Alcoholic Liver Injury.

Authors:  Jing-Hua Peng; Tuan Cui; Zhao-Lin Sun; Fu Huang; Liang Chen; Lin Xu; Qin Feng; Yi-Yang Hu
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-21       Impact factor: 2.629

Review 9.  Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.

Authors:  Ming Hong; Sha Li; Hor Yue Tan; Ning Wang; Sai-Wah Tsao; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

Review 10.  Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs.

Authors:  Uzma Latief; Riaz Ahmad
Journal:  J Tradit Complement Med       Date:  2017-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.